Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBloomsbury Share News (BMY)

Share Price Information for Bloomsbury (BMY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 536.00
Bid: 534.00
Ask: 538.00
Change: -4.00 (-0.74%)
Spread: 4.00 (0.749%)
Open: 550.00
High: 550.00
Low: 532.00
Prev. Close: 540.00
BMY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Thursday tips round-up: Jupiter Fund Management, Experian, Bloomsbury

Thu, 17th Jan 2013 06:58

Asset managers such as Jupiter Fund Management are not a bad proxy for investing in equities markets, if you believe the more optimistic projections for this year. Jupiter beat market forecasts for the amount of assets under management in the final quarter of last year as retail investors in Britain piled into its high-profile mutual funds. The amount invested in such funds grew by 917m pounds to 20.6bn pounds, more than half of this coming from new investment rather than an increase in their value as UK equities markets rose. The fallout from the Retail Distribution Review is also favourable long-term as investors switch to branded products, even if the next few months could see most involved sitting on their hands until the long-term picture looks clearer. Jupiter is now cash-positive and analysts expect to see this reflected in chunky rises in dividends over the next couple of years. But the shares, after a strong performance since last spring, are on 14 times earnings, which suggests that the run has come to an end unless you take a very bullish view of UK equities, The Times's Tempus column says. Information services company Experian yesterday revealed that revenue growth is slowing from the high levels seen previously, not least in Latin America, where the business in Brazil benefited from a one-off boost from changes in corporate taxation last time. Organic growth slackened from 9% in the first quarter to 7% in the third and will run at about that rate for the year. As well, Tempus points out, it has an inefficient balance sheet, thanks to its highly cash generative businesses, which has driven speculation of share buybacks, adding to the hefty multiple the shares enjoy. The shares, up 24p at £10.62, are back to their peak in October and trade on more than 20 times this year's earnings, which suggests that immediate progress could be limited, Tempus adds.Bloomsbury Publishing's strategy involves increasing its output of academic and professional publishing, which tend to be higher-margin products and offer more e-commerce opportunities. As well, the company has been pursuing an expansion in other English-speaking countries, such as India, as well as growing its "online knowledge hubs." Furthermore, yesterday's trading update showed that the company is making progress on multiple fronts. However, there is some uncertainty over the current-year consensus, hence the 2014 earnings multiple of 8.9 is looking pretty fair. Having said that, any downside is protected by the attractive 5% prospective yield. The Telegraph's Questor team therefore keeps a hold stance.Please note: Digital Look provides a round-up of news, tips and information that is impacting share prices and the market. Digital Look cannot take any responsibility for information provided by third parties. This is for your general information only as not intended to be relied upon by users in making an investment decision or any other decision. Please obtain a copy of the relevant publication and carry out your own research before considering acting on any of this information.AB
More News
26 Mar 2018 21:56

Reuters Health News Summary

Following is a summary of current health news briefs. Biohaven plunges as investors pit migraine data against Allergan's drug Biohaven Pharmaceutical Holding said its acute two a

Read more
26 Mar 2018 13:56

Reuters Health News Summary

Following is a summary of current health news briefs. Singapore pharma on recovery path after worst output in decades Singapore's among

Read more
26 Mar 2018 13:56

Reuters Health News Summary

Following is a summary of current health news briefs. Singapore pharma on recovery path after worst output in decades Singapore's among

Read more
26 Mar 2018 07:23

UPDATE 1-Roche's Tecentriq cocktail notches another lung cancer success

ZURICH, March 26 (Reuters) - Roche's immunotherapy Tecentriq combined with other drugs boosted lung cancer patients' survival versus an older cocktail, the Swiss trial

Read more
25 Mar 2018 14:15

Israel to launch Big Data health project

By Maayan Lubell JERUSALEM, March 25 (Reuters) - Israel will invest nearly 1 billion shekels ($287 million) in a to a

Read more
20 Mar 2018 07:05

UPDATE 1-Roche says Tecentriq, chemo cut risk of death in type of lung cancer

ZURICH, March 20 (Reuters) - Roche's immunotherapy Tecentriq plus chemotherapy cut the risk of disease worsening or death in advanced squamous lung cancer, but it did not

Read more
19 Mar 2018 17:59

Bloomsbury Publishing Expecting Profitability To Beat Expectations

LONDON (Alliance News) - Bloomsbury Publishing PLC said on Monday it expects its full-year profit and revenue to both be ahead of expectations.For the year ending 28 to

Read more
20 Jan 2017 09:08

Bloomsbury Publishing Says Chairman Salz To Step Down In July

Read more
27 Oct 2016 07:43

Bloomsbury Publishing Sees Stronger Second Half As Trading In Line

Read more
13 Jul 2016 12:55

Bloomsbury Publishing plots expansion into B2B market

(ShareCast News) - Harry Potter publisher Bloomsbury Publishing held a capital markets day for investors and analysts on Wednesday to present plans to enter the business-to-business market, while also confirming first-quarter trading remained in line with full year expectations. Bloomsbury unveiled

Read more
13 Jul 2016 08:20

Bloomsbury Publishing Says Full Year Trading To Meet Expectations

Read more
12 Jul 2016 15:11

UK Shareholder Meetings Calendar - Next 7 Days

Read more
8 Jul 2016 15:00

UK Shareholder Meetings Calendar - Next 7 Days

Read more
19 May 2016 12:43

Bloomsbury moves towards digital B2B after strong FY

(ShareCast News) - Bloomsbury, the publisher behind the Harry Potter phenomenon, has turned in an overall strong set of full-year results and launched a 2020 strategy to move into digital B2B publishing. It booked a full-year pretax profit of £10.36m, from a year-earlier profit of £9.60m, with reven

Read more
19 May 2016 08:18

Bloomsbury To Reoganise Divisions As Profit Lifted By Children's Books

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.